SOURCE: Millennium Dental Technologies

Millennium Dental Technologies

February 01, 2016 17:29 ET

The LANAP Protocol Continues to Help Patients Worldwide With New Pending Patent Application

CERRITOS, CA--(Marketwired - Feb 1, 2016) -  Millennium Dental Technologies, Inc. (MDT) announced today that it has a new patent pending on the LANAP® protocol. This patent is a comprehensive patent covering not only the LANAP protocol itself but also other laser-assisted protocols and innovations using the PerioLase® MVP-7-- the dental laser that makes the LANAP protocol possible. There are omnibus claims to both. 

"The LANAP protocol is a revolutionary clinical procedure for the treatment of periodontitis," said Dr. Robert Gregg II, founder of Millennium Dental Technologies Inc. and co-inventor of the LANAP protocol. "This patent pending protects the protocol for decades into the future." 

ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP® protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT's FDA-cleared and patented LANAP® protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional scalpel/suture flap surgery; its PerioLase® MVP-7™ is a 6-watt free-running variable-pulsed Nd:YAG dental laser featuring digital technology and 7 pulse durations -- the most available on the market -- giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures. The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the treatment of ailing and failing implants. Established in 1994, the company's founding clinician and inventor, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients -- and to remain true to the guiding principle -- "It's all about the patient." For more information, visit

Contact Information

  • Leslie Licano
    Beyond Fifteen Communications, Inc.
    Email Contact